Medicus Pharma MDCX Growth Metrics (2024-2026)

NASDAQ MDCX
$2.70 -0.02 (-0.74%)
As of: Oct 21, 2026 · 12:56 PM EDT
Reported Financials

Medicus Pharma Quarterly Growth Metrics

Periods 8 quarters
Latest Jun 2026

Medicus Pharma reported asset growth of 127.21% for the quarter ended Jun 2026. These growth metrics cover 8 quarters of results from Jun 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

1Y3Y5Y7Y10YAll
Download Data
Growth MetricsGrowth Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Growth Ratios
Assets Growth (1y) 198.29%78.18%127.21%
Assets (QoQ) 0.19%110.94%-16.40%0.84%
Cash & Equivalents Growth (1y)Cash & Equiv. Growth (1y) 142.21%109.04%56.93%
Cash & Equivalents (QoQ)Cash & Equiv. (QoQ) -4.37%142.81%-10.42%0.50%
Cash from Operations Growth (1y)Cash from Ops. Growth (1y) -234.85%-96.95%-117.85%-107.08%
Cash from Operations (QoQ)Cash from Ops. (QoQ) -135.93%-11.72%-2.89%-23.48%-38.77%-23.57%2.20%
EBIT Growth (1y) -200.25%-69.28%100.00%-117.28%-90.80%
EBIT Margin Growth (1y) 0.42M
EBIT Margin (QoQ) -0.31M1.50M
EBIT (QoQ) -108.15%34.32%-53.60%-42.97%-17.36%100.00%-51,937,233.33%
EBT Growth (1y) -198.85%-68.16%100.00%-117.28%-95.52%
EBT Margin Growth (1y) 0.42M
EBT Margin (QoQ) -0.31M1.49M
EBT (QoQ) -108.15%34.32%-53.60%-42.31%-17.12%100.00%-51,937,233.33%
EPS (Basic) Growth (1y) -97.19%2.79%-369.18%-137.11%51.19%
EPS (Basic) (QoQ) -110.40%46.15%-53.51%-13.38%-3.72%-159.89%22.42%
EPS (Diluted) Growth (1y) -97.19%2.79%-369.18%-137.11%51.19%
EPS (Diluted) (QoQ) -110.40%46.15%-53.51%-13.38%-3.72%-159.89%22.42%
FCF Margin Growth (1y) -5.28M
FCF Margin (QoQ) -0.09M-4.47M
Free Cash Flow Growth (1y)FCF Growth (1y) -234.85%-96.95%-117.85%-107.08%
Free Cash Flow (QoQ)FCF (QoQ) -135.93%-11.72%-2.89%-23.48%-38.77%-23.57%2.20%
Net Cash Flow Growth (1y)NCF Growth (1y) 84.55%-27.70%216.49%103.88%
Net Cash Flow (QoQ)NCF (QoQ) 768.33%-139.44%63.19%84.07%3,226.63%-36.46%-98.77%
Net Income Growth (1y) -198.85%-70.01%-818.74%-326.04%-89.19%
Net Income (QoQ) -112.78%37.27%-55.20%-44.28%-21.04%-238.98%28.03%
Net Income towards Common Stockholders Growth (1y)Net Income Growth (1y) -198.85%-70.01%-818.74%-326.05%-88.11%
Net Income towards Common Stockholders (QoQ)Net Income (QoQ) -112.78%37.27%-55.20%-44.28%-21.04%-238.98%28.03%
Net Margin Growth (1y) -17.68M
Net Margin (QoQ) -0.31M-16.55M
Operating Income Growth (1y)Op. Inc Growth (1y) -200.25%-69.28%100.00%-117.28%-90.80%
Operating Income (QoQ)Op. Inc (QoQ) -108.15%34.32%-53.60%-42.97%-17.36%100.00%-51,937,233.33%
Operating Margin Growth (1y) 0.42M
Operating Margin (QoQ) -0.31M1.50M
Profit After Tax Growth (1y)PAT Growth (1y) -198.85%-68.16%100.00%-117.28%-95.52%
Profit After Tax (QoQ)PAT (QoQ) -108.15%34.32%-53.60%-42.31%-17.12%100.00%-51,937,233.33%
Return on Assets [ROA] Growth (1y)ROA Growth (1y) 0.00M
Return on Assets [ROA] (QoQ)ROA (QoQ) 0.01M-0.01M-0.01M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y) 0.64M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ) -0.61M0.18M-1.83M
Return on Equity [ROE] (QoQ)ROE (QoQ) -0.03M-0.01M-0.20M
Return on Sales [ROS] Growth (1y)ROS Growth (1y) 0.42M
Return on Sales [ROS] (QoQ)ROS (QoQ) -0.31M1.50M
Revenue Growth (1y) 150.62%-79.15%-657.96%
Revenue (QoQ) 170.25%-11.92%-71.07%-2,457.62%
Share-based Compensation Growth (1y)Stock Comp. Growth (1y) 212.29%-79.94%368.48%
Share-based Compensation (QoQ)Stock Comp. (QoQ) 1,528.35%22.41%4.61%626.07%-49.61%
Total Debt Growth (1y) 357.08%
Total Debt (QoQ) 45.01%-22.65%

Medicus Pharma Growth Metrics API

Pull Medicus Pharma's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key. 

https://data.businessquant.com/statements?ticker=MDCX&statement=Growth&frequency=Quarter&period=all&api_key=YOUR_API_KEY
API documentation